Cataract & Refractive

Latest News


CME Content


Xibrom (bromfenac sodium ophthalmic solution) 0.09% (ISTA Pharmaceuticals, Inc.) achieved the primary endpoint of its Phase III trial: absence of ocular inflammation 15 days postoperatively.

BD launches new knife range

The BD range of Atomic Edge Limbal Relaxing Incision (LRI) knives for surgical correction of astigmatism has been launched by BD Medical. The knives, which feature a retractable safety shield, use single-crystal silicon, offering high performance at low cost.

B-MICS better than C-SICS

Biaxial microincision cataract surgery (B-MICS) is more successful than traditional cataract surgery in improving optical performance and reducing higher order aberrations, according to study results published in the December issue of the British Journal of Ophthalmology.

Paediatric strabismus, particularly exotropia, increases the likelihood of psychiatric disease in later life, according to study results published in the November issue of Pediatrics.

HOYA Surgical Optics has been distributing IOLs to ophthalmic surgeons in Europe since 2003. The name HOYA, however, represents more than just IOLs; the firm has a long tradition in high tech optics…

STAAR Surgical has created the Collamer Accommodating Study Team (CAST), a group of seven ophthalmologists who will investigate the accommodative properties of STAAR's Collamer intraocular lens (IOL).

The Phase IIb trial assessing the safety and efficacy of microplasmin in patients, showed complete resolution of vitreomacular traction or macular hole without need for vitrectomy surgery, according to a statement from the trial sponsor, ThromboGenics NV.

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.

Following limited reports of adverse events encountered by US physicians using a particular batch of Healon D viscoelastic, AMO has recalled the remaining products in the batch.

The Premium Experience Network (PEN), a membership programme designed to enhance the professional competitiveness of refractive surgeons? practices, has been launched by Shareef Mahdavi of SM2 Strategic.

The TearLab Osmolarity System and Osmolarity Test Card have been submitted to the FDA for premarket authorization in the US, according to an announcement from the manufacturer of TearLab, Occulogix.

Sensitivity analysis could determine the rate of human error in strabismus surgery and reduce the need for repeated operations, according to results published online ahead of print by Graefe's Archive for Clinical and Experimental Ophthalmology.

Multiple-use packs of preservative-free artificial tears are susceptible to contamination, according to study results published in the November issue of the British Journal of Ophthalmology.

Phaco decreases mortality

Contrary to accepted wisdom, cataract surgery decreases mortality rates, according to results published online ahead of print by the British Journal of Ophthalmology.

Crackdown!

As part of its crackdown on the use of unapproved drugs in the US, the FDA is warning all but two makers of balanced salt solution (BSS) to discontinue its manufacture and sale.

Dr Amar Agarwal and team describe a technique for adhering sutureless scleral-fixated IOLs with a biological fibrin sealant glue.

A young woman is suffering from a condition that leaves her blind, but only for half the time. For the last four years, Natalie Adler's eyes have regularly clamped shut for three days every week, and then reopened for the next three days.